Literature DB >> 10671089

Conjugate vaccines.

D Goldblatt.   

Abstract

Mesh：

Substances：

Year:  2000        PMID： 10671089      PMCID： PMC1905528          DOI： 10.1046/j.1365-2249.2000.01109.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  31 in total

1.  IgG1, IgG2 and IgM responses to two Haemophilus influenzae type b conjugate vaccines in young infants.

Authors:  D M Ambrosino; S K Sood; M C Lee; D Chen; H R Collard; D L Bolon; C Johnson; R S Daum
Journal:  Pediatr Infect Dis J       Date:  1992-10       Impact factor: 2.129

2.  Carriage of pneumococci after pneumococcal vaccination.

Authors:  S K Obaro; R A Adegbola; W A Banya; B M Greenwood
Journal:  Lancet       Date:  1996-07-27       Impact factor: 79.321

3.  The induction of immunologic memory after vaccination with Haemophilus influenzae type b conjugate and acellular pertussis-containing diphtheria, tetanus, and pertussis vaccine combination.

Authors:  D Goldblatt; P Richmond; E Millard; C Thornton; E Miller
Journal:  J Infect Dis       Date:  1999-08       Impact factor: 5.226

4.  Differences in the avidity of antibodies evoked by four different pneumococcal conjugate vaccines in early childhood.

Authors:  M Anttila; J Eskola; H Ahman; H Käyhty
Journal:  Vaccine       Date:  1999-04-09       Impact factor: 3.641

5.  A trial of a group A plus group C meningococcal polysaccharide-protein conjugate vaccine in African infants.

Authors:  P A Twumasi; S Kumah; A Leach; T J O'Dempsey; S J Ceesay; J Todd; C V Broome; G M Carlone; L B Pais; P K Holder
Journal:  J Infect Dis       Date:  1995-03       Impact factor: 5.226

6.  IgG subclass response to immunization with Haemophilus influenzae type b polysaccharide-outer membrane protein conjugate vaccine.

Authors:  D M Granoff; G A Weinberg; P G Shackelford
Journal:  Pediatr Res       Date:  1988-08       Impact factor: 3.756

7.  The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex.

Authors:  M Santosham; M Wolff; R Reid; M Hohenboken; M Bateman; J Goepp; M Cortese; D Sack; J Hill; W Newcomer
Journal:  N Engl J Med       Date:  1991-06-20       Impact factor: 91.245

8.  CHEMO-IMMUNOLOGICAL STUDIES ON CONJUGATED CARBOHYDRATE-PROTEINS : II. IMMUNOLOGICAL SPECIFICITY OF SYNTHETIC SUGAR-PROTEIN ANTIGENS.

Authors:  O T Avery; W F Goebel
Journal:  J Exp Med       Date:  1929-09-30       Impact factor: 14.307

9.  Haemophilus influenzae type b capsular polysaccharide vaccine in children: a double-blind field study of 100,000 vaccinees 3 months to 5 years of age in Finland.

Authors:  H Peltola; H Käyhty; A Sivonen; H Mäkelä
Journal:  Pediatrics       Date:  1977-11       Impact factor: 7.124

10.  Pneumococcal vaccine and otitis media.

Authors:  P H Mäkelä; M Sibakov; E Herva; J Henrichsen; J Luotonen; M Timonen; M Leinonen; M Koskela; J Pukander; S Pöntynen; P Grönroos; P Karma
Journal:  Lancet       Date:  1980-09-13       Impact factor: 79.321
View more
  50 in total

Review 1.  Proteomic contributions to our understanding of vaccine and immune responses.

Authors:  Allison C Galassie; Andrew J Link
Journal:  Proteomics Clin Appl       Date:  2015-09-10       Impact factor: 3.494

2.  Isolation and characterization of new human carrier peptides from two important vaccine immunogens.

Authors:  Paeton L Wantuch; Lina Sun; Rachel K LoPilato; Jarrod J Mousa; Robert S Haltiwanger; Fikri Y Avci
Journal:  Vaccine       Date:  2020-01-28       Impact factor: 3.641

3.  Routine infant vaccination of pneumococcal conjugate vaccines has decreased pneumonia across all age groups in Northern Spain.

Authors:  I Rivero-Calle; J Pardo Seco; P F Raguindin; F Alvez; J Gómez-Rial; A Salas; J Martinón Sanchez; F Martinón-Torres
Journal:  Hum Vaccin Immunother       Date:  2019-12-18       Impact factor: 3.452

Review 4.  Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed): in older adults.

Authors:  Mark Sanford
Journal:  Drugs       Date:  2012-06-18       Impact factor: 9.546

5.  Functional T-cell deficiency in adolescents who experience serogroup C meningococcal disease despite receiving the meningococcal serogroup C conjugate vaccine.

Authors:  Rachel A Foster; Jennifer Carlring; Andrew Lees; Ray Borrow; Mary Ramsay; Ed Kacsmarski; Elizabeth Miller; Michael W McKendrick; Andrew W Heath; Robert C Read
Journal:  Clin Vaccine Immunol       Date:  2010-05-12

Review 6.  Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed): a guide to its use in older adults.

Authors:  Lesley J Scott; Mark Sanford
Journal:  Drugs Aging       Date:  2012-10       Impact factor: 3.923

7.  Synthesis and immunogenicity of the Mycobacterium tuberculosis arabinomannan-CRM197 conjugate.

Authors:  Yunsong Chang; Xin Meng; Yaxin Li; Jianmei Liang; Tingshen Li; Demei Meng; Tao Zhu; Peng Yu
Journal:  Medchemcomm       Date:  2019-04-02       Impact factor: 3.597

8.  Use of Reverse Vaccinology in the Design and Construction of Nanoglycoconjugate Vaccines against Burkholderia pseudomallei.

Authors:  Laura A Muruato; Daniel Tapia; Christopher L Hatcher; Mridul Kalita; Paul J Brett; Anthony E Gregory; James E Samuel; Richard W Titball; Alfredo G Torres
Journal:  Clin Vaccine Immunol       Date:  2017-11-06

Review 9.  Meningococcal vaccines and herd immunity: lessons learned from serogroup C conjugate vaccination programs.

Authors:  Caroline L Trotter; Martin C J Maiden
Journal:  Expert Rev Vaccines       Date:  2009-07       Impact factor: 5.217

10.  Pneumococcal polysaccharides interact with human dendritic cells.

Authors:  Ulrike Meltzer; David Goldblatt
Journal:  Infect Immun       Date:  2006-03       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.